Interleukin-2, ganciclovir, and high-dose zidovudine for the treatment of AIDS-associated primary central nervous system lymphoma.
Aboulafia
David M
DM
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000188:drug therapy; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016543:Central Nervous System Neoplasms / Q000188:drug therapy* / Q000209:etiology; D004359:Drug Therapy, Combination; D015774:Ganciclovir / Q000627:therapeutic use; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use; D016483:Lymphoma, AIDS-Related / Q000188:drug therapy*; D008297:Male; D016312:Treatment Refusal; D015215:Zidovudine / Q000008:administration & dosage / Q000627:therapeutic use
D019380:Anti-HIV Agents; D000970:Antineoplastic Agents; D007376:Interleukin-2; D015215:Zidovudine; D015774:Ganciclovir